BARD ACCESS


The point is Access did not meet the 20% growth that corporate was promised, you felcher. You did not beat the number you committed to. We grew our business 17% and a lot of if came right out of your bottom line. Keep believing
your own logic and we will keep chipping away.

17% growth over 80% market share is more impressive than 17% growth on 5% market share. Billy Madison called and thinks you need to retake 4th grade.
 
Bard Access is the market leader in every product line. BSC has been ruined by Bard Access. Medcomp is a joke. AngioDynamics is a small player.

Take the job!
 


Write your reply...